Caremark Minnesota hGH kickback suit could be dropped; firm pleads guilty to mail fraud June 16.
CAREMARK hGH KICKBACK CHARGES IN MINNESOTA COULD BE DISMISSED with prejudice upon the Minneapolis federal court's review of Caremark's June 16 plea of guilty to two counts of mail fraud, one in Minnesota and one in Ohio. "Upon acceptance of this Plea Agreement and imposition of sentences by the District Courts, the U.S. shall move to dismiss with prejudice all Counts in which Caremark is named as a defendant in the Second Superseding Indictment filed as United States v. Brown et al." pending in Minneapolis federal court, the plea agreement states.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth